Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


European Journal of Endocrinology, Vol 131, Issue 6, 641-645
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soldani, R
Right arrow Articles by Yen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soldani, R
Right arrow Articles by Yen, S.

Articles

Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro

R Soldani, A Cagnacci, and SS Yen

Department of Reproductive Medicine, University of California San Diego, La Jolla.

The role of insulin-like growth factor I (IGF-I) and IGF-II on luteinizing hormone (LH) release is still unclear. The present study was performed to investigate modifications of basal and gonadotrophin-releasing hormone (GnRH)-stimulated (10(-9) mol/l) LH release, induced by 4-h and a 24-h incubation with physiological doses of IGF-I (1, 5 and 10 nmol/l) and IGF-II (5, 10 and 15 nmol/l) in comparison with insulin (0.0017, 0.1722 and 1.722 nmol/l), from primary cultures of male rat anterior pituitary cells. Both during the 4-h and the 24-h incubation, basal and GnRH-stimulated LH release were increased by IGF-I, IGF-II and insulin in a dose-dependent fashion. Present data confirm insulin's capability of potentiating anterior pituitary LH release from dispersed rat anterior pituitary cells in vitro, and reveal similar effects for physiological doses of IGF-I and IGF-II.


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
S.K. Blank, C.R. McCartney, and J.C. Marshall
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Hum. Reprod. Update, July 1, 2006; 12(4): 351 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. V. Mehta, K. S. Patel, M. S. Coffler, M. H. Dahan, R. Y. Yoo, J. S. Archer, P. J. Malcom, and R. J. Chang
Luteinizing Hormone Secretion Is Not Influenced by Insulin Infusion in Women with Polycystic Ovary Syndrome Despite Improved Insulin Sensitivity during Pioglitazone Treatment
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2136 - 2141.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Rose, P. Froment, V. Perrot, M. J. Quon, D. LeRoith, and J. Dupont
The Luteinizing Hormone-releasing Hormone Inhibits the Anti-apoptotic Activity of Insulin-like Growth Factor-1 in Pituitary {alpha}T3 Cells by Protein Kinase C{alpha}-mediated Negative Regulation of Akt
J. Biol. Chem., December 10, 2004; 279(50): 52500 - 52516.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Patel, M. S. Coffler, M. H. Dahan, R. Y. Yoo, M. A. Lawson, P. J. Malcom, and R. J. Chang
Increased Luteinizing Hormone Secretion in Women with Polycystic Ovary Syndrome Is Unaltered by Prolonged Insulin Infusion
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5456 - 5461.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Romualdi, M. Guido, M. Ciampelli, M. Giuliani, F. Leoni, C. Perri, and A. Lanzone
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome
Hum. Reprod., June 1, 2003; 18(6): 1210 - 1218.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Quesada and A. M. Etgen
Functional Interactions between Estrogen and Insulin-Like Growth Factor-I in the Regulation of alpha 1B-Adrenoceptors and Female Reproductive Function
J. Neurosci., March 15, 2002; 22(6): 2401 - 2408.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. M. Baker, B. Davies, W. W. Dickhoff, and P. Swanson
Insulin-Like Growth Factor I Increases Follicle-Stimulating Hormone (FSH) Content and Gonadotropin-Releasing Hormone-Stimulated FSH Release from Coho Salmon Pituitary Cells In Vitro
Biol Reprod, September 1, 2000; 63(3): 865 - 871.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Weil, F. Carré, O. Blaise, B. Breton, and P.-Y. Le Bail
Differential Effect of Insulin-Like Growth Factor I on in Vitro Gonadotropin (I and II) and Growth Hormone Secretions in Rainbow Trout (Oncorhynchus mykiss) at Different Stages of the Reproductive Cycle
Endocrinology, May 1, 1999; 140(5): 2054 - 2062.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. Zhen, M. Zakaria, A. Wolfe, and S. Radovick
Regulation of Gonadotropin-Releasing Hormone (GnRH) Gene Expression by Insulin-Like Growth Factor I in a Cultured GnRH-Expressing Neuronal Cell Line
Mol. Endocrinol., July 1, 1997; 11(8): 1145 - 1155.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.